查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1538917

按类型、性别和服务供应商皮肤填充剂市场：2024-2033 年全球机会分析和产业预测

Dermal Filler Market By Type (Hyaluronic acid , Calcium Hydroxylapatite , Poly L lactic Acid, Others), By Gender By Service Provider : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2021年全球皮肤填充剂市场价值为51.848亿美元，预计到2031年将达到144.184亿美元，2022年至2031年的复合年增长率为10.8%。

皮肤填充剂被定义为注射到皮肤表面下方以增加丰满度和体积、抚平细纹、软化皱纹并增强脸部轮廓的美容手术。广泛用于脸部美容疗程。皮肤填充剂的类型包括透明质酸、羟基羟磷石灰、聚乳酸和聚甲基丙烯酸甲酯微球。这用于增强或填充脸部的浅层区域。此手术也常用于改善眼部皱纹。

真皮填充剂市场-IMG1

全球皮肤填充剂市场的成长主要是由于微创手术需求的显着增长、政府为推进皮肤填充剂手术而采取的倡议不断增加、皮肤填充剂产品的核准数量迅速增加以及透明质酸的采用不断增加。根据《皮肤病学与莫氏外科研究所日誌》报导，皮肤填充剂被分析为全球领先的微创皮肤手术之一。例如，2021年，领先的专业服务公司之一德勤报告称，中国消耗了约9.53%的透明质酸。因此，透明质酸的日益普及将推动对皮肤填充剂手术的需求。

此外，2021 年，美国食品药物管理局(FDA) 宣布批准 RHA 真皮填充剂用于治疗 22 岁及以上成年人的中度至重度动态口周皱襞（唇纹）。此外，生技公司 Revance Therapeutics, Inc. 于 2021 年发布了有关其 RHA皮肤填充剂系列的功效和安全性资料。这是透明质酸填充剂技术的最新进展之一，用于治疗深色肤色的中度至重度法令纹。皮肤填充剂技术的不断进步旨在实现持久有效的效果。因此，新兴国家先进皮肤填充剂产品的技术进步预计将推动市场成长。

政府对整容手术的支持不断增加以及整容手术需求的激增是推动全球皮肤填充剂市场的主要因素。例如，2022年2月，英国政府宣布将为皮肤填充剂和肉毒桿菌等非手术整容手术引入许可製度。这项措施旨在保护公众免受假冒填充剂和肉毒桿菌的侵害。此外，抗衰老治疗的兴起对市场成长做出了重大贡献。年轻人对外观美学需求的不断增长是全球市场扩张的主要动力。

然而，与皮肤填充剂手术相关的高成本预计将阻碍市场成长。皮肤过早老化现象的日益普遍，导致对透明质酸的需求急剧增加，推动了市场的成长。这进一步鼓励了许多主要参与者进入新兴市场，为皮肤填充剂市场提供了利润丰厚的成长机会。

皮肤填充剂市场按类型、性别、服务供应商和地区细分。依类型划分，市场分为透明质酸（HA）、羟基磷灰石钙（CaHA）、聚左旋乳酸等。另一部分则进一步分为聚甲基丙烯酸甲酯微球（PMMA）和脂肪组织。从性别上来说，分为男性和女性。依服务提供者分类，可分为专科/皮肤科诊所、医院等。从区域来看，分析涵盖北美、欧洲、亚太地区和拉丁美洲/中东/非洲。

相关人员的主要利益

  • 该报告提供了 2021 年至 2031 年皮肤填充剂市场分析的细分市场、当前趋势、估计和动态的定量分析，并确定了一般皮肤填充剂市场机会。
  • 我们提供市场研究以及与市场驱动因素、市场限制和市场机会相关的资讯。
  • 波特的五力分析揭示了买家和供应商的潜力，帮助相关人员做出利润驱动的业务决策并加强供应商和买家网路。
  • 皮肤填充剂市场区隔的详细分析有助于识别市场机会。
  • 每个地区的主要国家都根据其对全球市场的收益贡献绘製了地图。
  • 市场参与者定位有助于基准化分析，并提供对市场参与者当前位置的清晰了解。
  • 该报告包括对区域和全球皮肤填充剂市场趋势、主要企业、细分市场、应用领域和市场成长策略的分析。

目录

第一章简介

第 2 章执行摘要

第三章市场概况

  • 市场定义和范围
  • 主要发现
    • 影响因素
    • 主要投资机会
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
  • COVID-19 市场影响分析
  • 专利情况

第四章皮肤填充剂市场：依类型

  • 概述
  • 透明质酸（HA）
    • 透明质酸（HA）皮肤填充剂市场，依年龄层划分
  • 羟基磷灰石钙 (CaHA)
  • 聚乳酸
  • 其他的

第五章皮肤填充剂市场：依性别

  • 概述
  • 男性
  • 女士

第六章皮肤填充剂市场：依服务供应商

  • 概述
  • 专科和皮肤科诊所
  • 医院
  • 其他的

第七章皮肤填充剂市场：依地区

  • 概述
  • 北美洲
    • 北美透明质酸 (HA)皮肤填充剂市场：依年龄组别
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲透明质酸 (HA)皮肤填充剂市场：依年龄组别
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 亚太地区透明质酸 (HA)皮肤填充剂市场：依年龄组别
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 其他的
  • 拉丁美洲/中东/非洲
    • 拉丁美洲、中东和非洲的透明质酸 (HA)皮肤填充剂市场：按年龄划分
    • 巴西
    • 沙乌地阿拉伯
    • 哥伦比亚
    • 其他的

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2021年）

第九章 公司简介

  • AbbVie Laboratories
  • Bioxis pharmaceutical
  • Cutera Inc
  • Elan aesthetics Inc
  • Galderma SA
  • Merz Pharma GmbH and Co. KGaA
  • Revance Therapeutics
  • Sinclair Pharma
  • Teoxane Laboratories
  • Vital Esthetique Laboratories
简介目录
Product Code: A07289

The global dermal filler market was valued at $5,184.8 million in 2021, and is projected to reach $14,418.4 million by 2031, registering a CAGR of 10.8% from 2022 to 2031. Dermal filler is defined as an aesthetic procedure, which is injected beneath the surface of the skin to add fullness & volume, smooth lines & soften creases, and increase the facial contours. It is widely used for facial aesthetic treatment. The different types of dermal filler are hyaluronic acid, calcium hydroxylapatite, polylactic acid, and polymethyl-methacrylate microspheres. It is used to enhance or fill the shallow areas on the face. In addition, this procedure is mostly used among population to reduce wrinkle under eyes.

Dermal Filler Market - IMG1

The growth of the global dermal filler market is majorly driven by an alarming increase in demand for minimally invasive procedure; rise in government initiative for the advancement of dermal filler procedure; surge in the number of approvals for dermal filler' products; and a rise in adoption of hyaluronic acid. According to the journal of Dermatology & Mohs Surgery Institute, it was analyzed that dermal filler is one of the leading minimally invasive skin procedure, globally. For instance, in 2021, Deloitte, one of the leading professional services companies, reported that around 9.53% of hyaluronic acid is consumed in China. Thus, the increase in prevalence of hyaluronic acid boosts the demand for dermal filler procedure.

Moreover, in 2021, the U.S. Food and drug Administration (FDA) announced the approval of RHA Redensity Dermal Filler, which is used for the treatment of moderate to severe dynamic perioral rhytids (lip lines) in the adults above the age of 22. Furthermore, in 2021, Revance Therapeutics, Inc., a biotechnology company, presented data on the effectiveness and safety of the RHA collection of dermal filler. It is one of the latest advances in hyaluronic acid filler technology, which is used for the treatment of moderate-to-severe nasolabial folds in darker skin color. The increase in advancements in dermal filler technology aims to obtain long-lasting, and effective results. Thus, advancements in technology for advanced dermal filler products in emerging nations are expected to propel the growth of the market.

The increase in government support for aesthetic procedure and surge in demand for aesthetic procedure are the major factors that drive the global dermal filler market. For instance, in February 2022, the GOV.UK announced to introduce a licensing regime for non-surgical cosmetic procedures such as dermal filler and Botox. This step aims to protect the public against botch fillers and botox. In addition, increase in the number of anti-aging treatment significantly contributes toward the market growth. Rise in demand for aesthetic looks among young population acts a key driving force for the expansion of the global market.

However, the high cost associated with dermal filler procedure is anticipated to hinder the market growth. Increase in prevalence of early skin aging, surge the need for hyaluronic acid and drive the growth of the market. This has further encouraged many key players to enter emerging markets, thus offering a lucrative growth opportunity in the dermal filler market.

The dermal filler market is segmented into type, gender, service provider, and region. By type, the market is categorized into hyaluronic acid (HA), calcium hydroxylapatite (CaHA), poly-L-lactic acid, and others. The others segment is further divided into polymethyl-methacrylate microspheres (PMMA) and fat face. By gender, it is bifurcated into male and female. By service provider, the market is classified into specialty & dermatology clinics, hospitals, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global dermal filler market are include AbbVie Laboratories, Bioxis pharmaceutical, Cutera Inc., Elan aesthetics Inc., Galderma SA, Merz Pharma GmbH & Co. KGaA, Revance Therapeutics, Sinclair Pharma, Teoxane Laboratories, and Vital Esthetique Laboratories.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the dermal filler market analysis from 2021 to 2031 to identify the prevailing dermal filler market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the dermal filler market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global dermal filler market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Key Market Segments

By Type

  • Hyaluronic acid (HA)
    • Age group

◦ 13 to 39

◦ 40 to 54

◦ 55 to 69

  • Calcium Hydroxylapatite (CaHA)
  • Poly L lactic Acid
  • Others

By Gender

  • Male
  • Female

By Service Provider

  • Specialty and Dermatology Clinics
  • Hospitals
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Teoxane Laboratories
    • Cutera Inc
    • Elan aesthetics Inc
    • Bioxis pharmaceutical
    • AbbVie Laboratories
    • Sinclair Pharma
    • Sosum Global
    • Revance Therapeutics
    • Galderma SA
    • Merz Pharma

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities
  • 3.5. COVID-19 Impact Analysis on the market
  • 3.6. Patent Landscape

CHAPTER 4: DERMAL FILLER MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Hyaluronic acid (HA)
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
    • 4.2.4. Hyaluronic acid (HA) Dermal Filler Market by Age group
      • 4.2.4.1. 13 to 39 Market size and forecast, by region
      • 4.2.4.2. 40 to 54 Market size and forecast, by region
      • 4.2.4.3. 55 to 69 Market size and forecast, by region
  • 4.3. Calcium Hydroxylapatite (CaHA)
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Poly L lactic Acid
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. Others
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country

CHAPTER 5: DERMAL FILLER MARKET, BY GENDER

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Male
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Female
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country

CHAPTER 6: DERMAL FILLER MARKET, BY SERVICE PROVIDER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Specialty and Dermatology Clinics
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Hospitals
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: DERMAL FILLER MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key trends and opportunities
    • 7.2.2. Market size and forecast, by Type
      • 7.2.2.1. North America Hyaluronic acid (HA) Dermal Filler Market by Age group
    • 7.2.3. Market size and forecast, by Gender
    • 7.2.4. Market size and forecast, by Service Provider
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Key market trends, growth factors and opportunities
      • 7.2.5.1.2. Market size and forecast, by Type
      • 7.2.5.1.3. Market size and forecast, by Gender
      • 7.2.5.1.4. Market size and forecast, by Service Provider
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Key market trends, growth factors and opportunities
      • 7.2.5.2.2. Market size and forecast, by Type
      • 7.2.5.2.3. Market size and forecast, by Gender
      • 7.2.5.2.4. Market size and forecast, by Service Provider
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Key market trends, growth factors and opportunities
      • 7.2.5.3.2. Market size and forecast, by Type
      • 7.2.5.3.3. Market size and forecast, by Gender
      • 7.2.5.3.4. Market size and forecast, by Service Provider
  • 7.3. Europe
    • 7.3.1. Key trends and opportunities
    • 7.3.2. Market size and forecast, by Type
      • 7.3.2.1. Europe Hyaluronic acid (HA) Dermal Filler Market by Age group
    • 7.3.3. Market size and forecast, by Gender
    • 7.3.4. Market size and forecast, by Service Provider
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Key market trends, growth factors and opportunities
      • 7.3.5.1.2. Market size and forecast, by Type
      • 7.3.5.1.3. Market size and forecast, by Gender
      • 7.3.5.1.4. Market size and forecast, by Service Provider
      • 7.3.5.2. France
      • 7.3.5.2.1. Key market trends, growth factors and opportunities
      • 7.3.5.2.2. Market size and forecast, by Type
      • 7.3.5.2.3. Market size and forecast, by Gender
      • 7.3.5.2.4. Market size and forecast, by Service Provider
      • 7.3.5.3. UK
      • 7.3.5.3.1. Key market trends, growth factors and opportunities
      • 7.3.5.3.2. Market size and forecast, by Type
      • 7.3.5.3.3. Market size and forecast, by Gender
      • 7.3.5.3.4. Market size and forecast, by Service Provider
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Key market trends, growth factors and opportunities
      • 7.3.5.4.2. Market size and forecast, by Type
      • 7.3.5.4.3. Market size and forecast, by Gender
      • 7.3.5.4.4. Market size and forecast, by Service Provider
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Key market trends, growth factors and opportunities
      • 7.3.5.5.2. Market size and forecast, by Type
      • 7.3.5.5.3. Market size and forecast, by Gender
      • 7.3.5.5.4. Market size and forecast, by Service Provider
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Key market trends, growth factors and opportunities
      • 7.3.5.6.2. Market size and forecast, by Type
      • 7.3.5.6.3. Market size and forecast, by Gender
      • 7.3.5.6.4. Market size and forecast, by Service Provider
  • 7.4. Asia-Pacific
    • 7.4.1. Key trends and opportunities
    • 7.4.2. Market size and forecast, by Type
      • 7.4.2.1. Asia-Pacific Hyaluronic acid (HA) Dermal Filler Market by Age group
    • 7.4.3. Market size and forecast, by Gender
    • 7.4.4. Market size and forecast, by Service Provider
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. China
      • 7.4.5.1.1. Key market trends, growth factors and opportunities
      • 7.4.5.1.2. Market size and forecast, by Type
      • 7.4.5.1.3. Market size and forecast, by Gender
      • 7.4.5.1.4. Market size and forecast, by Service Provider
      • 7.4.5.2. Japan
      • 7.4.5.2.1. Key market trends, growth factors and opportunities
      • 7.4.5.2.2. Market size and forecast, by Type
      • 7.4.5.2.3. Market size and forecast, by Gender
      • 7.4.5.2.4. Market size and forecast, by Service Provider
      • 7.4.5.3. India
      • 7.4.5.3.1. Key market trends, growth factors and opportunities
      • 7.4.5.3.2. Market size and forecast, by Type
      • 7.4.5.3.3. Market size and forecast, by Gender
      • 7.4.5.3.4. Market size and forecast, by Service Provider
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Key market trends, growth factors and opportunities
      • 7.4.5.4.2. Market size and forecast, by Type
      • 7.4.5.4.3. Market size and forecast, by Gender
      • 7.4.5.4.4. Market size and forecast, by Service Provider
      • 7.4.5.5. Rest of Asia-Pacific
      • 7.4.5.5.1. Key market trends, growth factors and opportunities
      • 7.4.5.5.2. Market size and forecast, by Type
      • 7.4.5.5.3. Market size and forecast, by Gender
      • 7.4.5.5.4. Market size and forecast, by Service Provider
  • 7.5. LAMEA
    • 7.5.1. Key trends and opportunities
    • 7.5.2. Market size and forecast, by Type
      • 7.5.2.1. LAMEA Hyaluronic acid (HA) Dermal Filler Market by Age group
    • 7.5.3. Market size and forecast, by Gender
    • 7.5.4. Market size and forecast, by Service Provider
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Key market trends, growth factors and opportunities
      • 7.5.5.1.2. Market size and forecast, by Type
      • 7.5.5.1.3. Market size and forecast, by Gender
      • 7.5.5.1.4. Market size and forecast, by Service Provider
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Key market trends, growth factors and opportunities
      • 7.5.5.2.2. Market size and forecast, by Type
      • 7.5.5.2.3. Market size and forecast, by Gender
      • 7.5.5.2.4. Market size and forecast, by Service Provider
      • 7.5.5.3. Colombia
      • 7.5.5.3.1. Key market trends, growth factors and opportunities
      • 7.5.5.3.2. Market size and forecast, by Type
      • 7.5.5.3.3. Market size and forecast, by Gender
      • 7.5.5.3.4. Market size and forecast, by Service Provider
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Key market trends, growth factors and opportunities
      • 7.5.5.4.2. Market size and forecast, by Type
      • 7.5.5.4.3. Market size and forecast, by Gender
      • 7.5.5.4.4. Market size and forecast, by Service Provider

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2021

CHAPTER 9: COMPANY PROFILES

  • 9.1. AbbVie Laboratories
    • 9.1.1. Company overview
    • 9.1.2. Key Executives
    • 9.1.3. Company snapshot
  • 9.2. Bioxis pharmaceutical
    • 9.2.1. Company overview
    • 9.2.2. Key Executives
    • 9.2.3. Company snapshot
  • 9.3. Cutera Inc
    • 9.3.1. Company overview
    • 9.3.2. Key Executives
    • 9.3.3. Company snapshot
  • 9.4. Elan aesthetics Inc
    • 9.4.1. Company overview
    • 9.4.2. Key Executives
    • 9.4.3. Company snapshot
  • 9.5. Galderma SA
    • 9.5.1. Company overview
    • 9.5.2. Key Executives
    • 9.5.3. Company snapshot
  • 9.6. Merz Pharma GmbH and Co. KGaA
    • 9.6.1. Company overview
    • 9.6.2. Key Executives
    • 9.6.3. Company snapshot
  • 9.7. Revance Therapeutics
    • 9.7.1. Company overview
    • 9.7.2. Key Executives
    • 9.7.3. Company snapshot
  • 9.8. Sinclair Pharma
    • 9.8.1. Company overview
    • 9.8.2. Key Executives
    • 9.8.3. Company snapshot
  • 9.9. Teoxane Laboratories
    • 9.9.1. Company overview
    • 9.9.2. Key Executives
    • 9.9.3. Company snapshot
  • 9.10. Vital Esthetique Laboratories
    • 9.10.1. Company overview
    • 9.10.2. Key Executives
    • 9.10.3. Company snapshot